Psychosocial factors and quality of life in colorectal cancer

Surgeon

Volumn 5, Issue 6, 2007, Pages 344-354

  Sharma, A ^a   Walker, A A ^a   Sharp, D M ^a   Monson, J R T ^a   Walker, L G ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Colorectal cancer; Psychology; Quality of life

Indexed keywords

EID: 36849054960     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(07)80087-4     Document Type: Review

References (72)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94(2): 153-6
2. Becker N, Muscat JE, Wynder EL. Cancer mortality in the United States and Germany. J Cancer Res Clin Oncol 2001; 127(5): 293-300
3. Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994; 330: 1136-42
4. HMSO. OPCS. Mortality statistics; cause 1993. DH2, No 22. 1995. London. Ref Type: Report
5. Coleman MP et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004; 90(7): 1367-73
6. Holland JC. Psycho-oncology, New York: Oxford University Press, 1998
7. Walker LG et al. Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer 1999; 80(1-2): 262-8
8. Ferrans CE. Quality of life: conceptual issues. Semin Oncol Nurs 1990; 6(4): 248-54
9. Morton RP. Life-satisfaction in patients with head and neck cancer. Clin Otolaryngol 1995; 20(6): 499-503
10. Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest 1993; 11(3): 327-36
11. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273(1): 59-65
12. Ringash J, Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck 2001; 23(3): 201-13
13. Aaronson NK et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5): 365-76
14. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994; 272(8): 619-26
15. Sprangers MA, Taal BG, Aaronson NK, TE VA. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum 1995; 38(4): 361-9
16. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. [No authors listed] American Society of Clinical Oncology. J Clin Oncol 1996; 14: 671-9
17. Conroy T, Bleiberg H, Glimelius B. Quality of life in patients with advanced colorectal cancer: what has been learnt? Eur J Cancer 2003; 39(3): 287-94
18. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996; 14(1): 171-5
19. Maisey NR et al. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002; 38(10): 1351-7
20. Smyth JF et al. Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer. Ann Oncol 1995; 6(9): 948-9
21. Mormont MC et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000; 6(8): 3038-45
22. Maughan TS et al. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. Lancet 2002; 359: 1555-63
23. Walker LG et al. Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. Eur J Cancer 1999; 35(13): 1783-8
24. Cunningham D et al. Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group. Ann Oncol 1996; 7(9): 961-5
25. Lesley Fallowfield. The quality of life- the missing measurement in health care. London: Souvenir Press, 1990
26. Hays RD, Anderson RT, Revicki D. Assessing reliability and validity of measurement in clinical trials. In: Staquet MJ, Hays RD, Fayers PM eds. Quality of life assessment in clinical trials: methods and practice. New York: Oxford University Press, 1998: 169-82
27. Camilleri-Brennan J, Steele RJ. Measurement of quality of life in surgery. J R Coll Surg Edinb 1999; 44: 252-9
28. Hays RD, Hadorn D. Responsiveness to change: an aspect of validity, not a separate dimension. Qual Life Res 1992; 1: 73-5
29. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988; 57: 109-12
30. Velikova G, Brown JM, Smith AB, Selby PJ. Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer 2002; 86(1): 51-9
31. Wright EP et al. Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 2003; 21(2): 374-82
32. Cull A et al. Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Br J Cancer 2001; 85(12): 1842-9
33. Osoba D. Guidelines for measuring health-related quality of life in clinical trials. In: Hays RD, Anderson RT, Revicki D eds. Quality of life assessment in clinical trials: methods and practice. New York: Oxford University Press, 1998: 19-35
34. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30(6): 473-83
35. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. NFER-Nelson Windsor: 1988
36. Gilson ES et al. The sickness impact profile. Development of an outcome measure of health care. Am J Public Health 1975; 65: 1304-10
37. Carr-Hill RA, Kind P. The Nottingham Health Profile. Soc Sci Med 1989; 28: 885
38. Zigmond AS, Snaith RR The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70
39. Cella DF et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11(5): 570-9
40. Sprangers MA, TE VA, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 1999; 35: 238-47
41. Ward WL et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res 1999; 8(3): 181-95
42. de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62(2): 1034-8
43. Joyce CR. How can we measure individual quality of life? Schweiz Med Wochenschr 1994; 124: 1921-6
44. O'Boyle CA, McGee H, Hickey A, O'Malley K, Joyce CR. Individual quality of life in patients undergoing hip replacement. Lancet 1992; 339: 1088-91
45. Joyce CR, Hickey A, McGee HM, O'Boyle CA. A theory-based method for the evaluation of individual quality of life: the SEIQoL. Qual Life Res 2003; 12: 275-80
46. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care 1994; 32: 1109-26
47. Camilleri-Brennan J, Ruta DA, Steele RJ. Patient generated index: new instrument for measuring quality of life in patients with rectal cancer. World J Surg 2002; 26: 1354-9
48. Moons P, Marquet K, Budts W, De Geest S. Validity, reliability and responsiveness of the "Schedule for the Evaluation of Individual Quality of Life-Direct Weighting" (SEIQoL-DW) in congenital heart disease. Health Qual Life Outcomes 2004; 2: 27
49. King Edward's Hospital Fund for London. King's Fund Centre for Health Services Development. Cancer of the colon and rectum: the seventh King's Fund Forum consensus statement. 1990. London, King's Fund Centre. Ref Type: Report
50. Derogatis LR et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249(6): 751-7
51. Ford S. Lewis S, Fallowfield L. Psychological morbidity in newly referred patients with cancer. J Psychosom Res 1995; 39(2): 193-202
52. Nordin K, Glimelius B. Psychological reactions in newly diagnosed gastrointestinal cancer patients. Acta Oncol 1997; 36(8): 803-10
53. Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer 2002; 94(10): 2719-27
54. Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-oncology 2001; 10(1): 19-28
55. Sprangers MA, Velde AT, Aaronson NK, Babs TG. Quality of life following surgery for colorectal cancer: a literature review.] Psycho-oncology 1993; 2: 247-59
56. MacDonald LD, Anderson HR. The health of rectal cancer patients in the community. Eur J Surg Oncol 1985; 11(3): 235-41
57. L.G.Walker et al. The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial. Psycho-oncology 1997; 6: 290-301
58. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-60
59. Anthony T, Jones C, Antoine J, Sivess-Franks S, Turnage R, The effect of treatment for colorectal cancer on long-term health-related quality of life. Ann Surg Oncol 2001; 8(1): 44-9
60. Williams NS, Johnston D. The quality of life after rectal excision for low rectal cancer. Br J Surg 1983; 70(8): 460-2
61. Engel J et al. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 2003; 238(2): 203-13
62. Camilleri-Brennan J, Steele RJ. Objective assessment of morbidity and quality of life after surgery for low rectal cancer. Colorectal Dis 2002; 4(1): 61-6
63. Kune GA, Kune S, Watson LF, Balinson CB. Personality as a risk factor in large bowel cancer: data from the Melbourne Colorectal Cancer Study, Psychol Med 1991; 21: 29-41
64. Rauch P, Miny J, Conroy T, Neyton L, Guillemin F. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 2004; 22(2): 354-60
65. Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol 2004; 22(23): 4829-36
66. Rijken M, Komproe IH, Ros WJ, Winnubst JA, van Heesch NC. Subjective well-being of elderly women: conceptual differences between cancer patients, women suffering from chronic ailments and healthy women. Br J Clin Psychol 1995; 34(Pt 2): 289-300
67. Cassileth BF, Lusk EJ, Miller DS, Brown LL, Miller C. Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 1985; 312(24): 1551-5
68. Cassileth BR, Walsh WP, Lusk EJ. Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis. J Clin Oncol 1988; 6(11): 1753-9
69. Johansen C, Schou G, Soll-Johanning H, Mellemgaard A, Lynge E. [Marital status and survival in colorectal cancer]. Ugeskr Laeger 1998; 160(5): 635-8
70. Camilleri-Brennan J, Steele RJ. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. Br J Surg 2001; 88(12): 1617-22
71. Kuchler T et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 1999; 46(25): 322-35
72. Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer patients. Cancer 1982; 49(5): 1048-55